As the activation of NRF2 in cancer is two-sided [36,89], its functions are more far-reaching than originally envisioned, which presents new challenges and opportunities for targeting NRF2 and NQO1 in skin cancer prevention and treatment [90]. The gene discussed is NQO1; the disease is skin cancer.